Default Category
-
Cells For Life (B)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E011-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing.Starting at €5.74
-
Glenwood Laboratories Canada Ltd.: Coping with Tariff War
Nouri Najjar; Ramasastry ChandrasekharCase IVEY-9B19M116-EEntrepreneurship, StrategyIn August 2018, Glenwood Laboratories Canada Ltd. (Glenwood), an importer of medical devices from the United States, is caught in the crossfire of public policy. In June 2018, the United States imposed a 10 per cent tariff on the import of raw aluminum frStarting at €8.20
-
Cells For Life (A)
John G. Wilson; Robert Young; Georg Oppitz; Wayne Hoy; David BassinCase IVEY-9B09E010-ECorporate Governance, Service and Operations ManagementA biotech company receives umbilical cells for processing. A number of operational improvements are being considered in order to maintain the company's position and reputation in the market. Information on expected delivery dates is known. However, there is a great uncertainty around these dates. The company needs to take account of this variability when arranging for staffing. A supporting data set is available, product 7B09E010 for the (A) case...Starting at €8.20